Buscador de publicaciones

Publicaciones

  • Stempel DA, Raphiou IH, Kral KM, Yeakey AM, Emmett AH, Prazma CM, Buaron KS, Pascoe SJ and AUSTRI Investigators.

    Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone

    NEW ENGLAND JOURNAL OF MEDICINE . 374(19): 1822-1830. Nº de citas: 131

    [doi:10.1056/NEJMoa1511049]

  • Vestbo J, Anderson JA, Brook RD, Calverley PM, Celli BR, Crim C, Martinez F, Yates J, Newby DE and SUMMIT Investigators.

    Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial

    Lancet . 387(10030): 1817-1826. Nº de citas: 352

    [doi:10.1016/S0140-6736(16)30069-1]

  • Lores L, de Burgoa VS and Chaves-Puertas J.

    Assessment of inspiratory flow in bronchial asthma by using a portable meter

    ALLERGY AND ASTHMA PROCEEDINGS . 36(6): 487-492. Nº de citas: 1

    [doi:10.2500/aap.2015.36.3885]

  • Alibakhshi E, Lores L and Raffaele Fiorillo.

    Physiological Factors Relevant to Exercise Tests in Pulmonary Rehabilitation of COPD Patients

    Journal of Sports Medicine & Doping Studies . 6: 167-167.

    [doi:10.4172/2161-0673.1000167]

  • Saleh A, López-Campos JL, Hartl S, Pozo-Rodríguez F and Roberts CM.

    The Effect of Incidental Consolidation on Management and Outcomes in COPD Exacerbations: Data from the European COPD Audit.

    PLoS One . 10(7): . Nº de citas: 28

    [doi:10.1371/journal.pone.0134004]

  • Lacoma A, Prat C, Andreo F, Lores L, Ruiz-Manzano J, Ausina V and Domínguez J.

    Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease.

    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE . 6: 157-169. Nº de citas: 62

    [doi:10.2147/COPD.S16070]

  • Lacoma A, Prat C, Andreo F, Lores L, Latorre I, Pérez M, Ruiz-Manzano J, Ausina V and Dominguez J.

    Usefulness of mid regional pro-atrial natriuretic peptide in the exacerbations of chronic obstructive pulmonary disease

    CLINICA CHIMICA ACTA . 412(5-6): 470-475. Nº de citas: 9

    [doi:10.1016/j.cca.2010.11.032]

  • Juan, Antoni, Enjamio, Eva, Moya, Carles, Garcia Fortea, Cristina, Castellanos, Juan, Perez Mas, Joan Ramon, Martinez Milan, Javier, Lores L, Urgelles, Joan, Robles B, Bou, Ester, Romero C, Mendez, Josep, Saavedra, Jose, Céspedes M, Morera, Marta, Vera, Rafael, Ferriz, Concepcion, Tor, Sara and Ramon, Rosa.

    Impact of hospital management measures on improving the efficiency of bed allocation and reducing emergency department overcrowding

    EMERGENCIAS . 22(4): 249-253. Nº de citas: 45

  • Andreo F, Ruiz-Manzano J, Prat C, Lores L, Blanco S, Malet A, Gallardo X and Domínguez J.

    Utility of pneumococcal urinary antigen detection in diagnosing exacerbations in COPD patients

    RESPIRATORY MEDICINE . 104(3): 397-403. Nº de citas: 21

    [doi:10.1016/j.rmed.2009.10.013]

  • Juan, A, Enjamio, E, Moya, C, Carlos Garcia Forero, Castellanos J, Pérez, JR, Martínez Milan, X, Lores L, Urgellés J, Robles B, Bou, E, Romero C, Mendez, JR, JOSEP SAAVEDRA LÓPEZ , Cespedes, M, Morera MM, Vera, R, Ferriz, C, Tor, S and Ramon, R.

    Impacto de la implementación de medidas de gestión hospitalaria para aumentar la eficiencia en la gestión de camas y disminuir la saturación del servicio de urgencias

    EMERGENCIAS . 22(4): 249-253.